CS
LABU icon

Credit Suisse’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Credit Suisse’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,500
Closed -$3.15M – 4227
2017
Q2 		$3.15M Hold
2,500
– – ﹤0.01% 1916
2017
Q1 		$2.39M Buy
+2,500
New +$2.23M ﹤0.01% 2224

Other funds holding LABU

Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
HJMC
Hellman Jordan Management Company Quincy, Massachusetts $58.9M AUM 18.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EWA
Exencial Wealth Advisors Oklahoma City, Oklahoma $3.22B AUM 20.17% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
TCM
Traynor Capital Management Malvern, Pennsylvania $1.7B AUM 39.15% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return

Credit Suisse's LABU Position: Q3 2017 in Review

Credit Suisse sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q3 2017, closing a stake of 2,500 shares — an estimated $3.15M sold.

Credit Suisse first reported a position in LABU in Q1 2017 and held it in 2 quarters. The position peaked at $3.15M in Q2 2017. 17 funds tracked by Wall St. Rank hold LABU as of Q3 2017.

  • Credit Suisse reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q3 2017 after selling out during the quarter.
  • Credit Suisse sold 2,500 Direxion Daily S&P Biotech Bull 3X ETF shares in Q3 2017, an estimated $3.15M.
  • Credit Suisse first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2017 and held it in 2 quarters.
  • Credit Suisse's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $3.15M in Q2 2017.
  • 17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2017.

Based on Credit Suisse's 13F filing for Q3 2017, filed 14 Nov 2017.